247 related articles for article (PubMed ID: 29141886)
1. PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.
Ben Nasr M; Tezza S; D'Addio F; Mameli C; Usuelli V; Maestroni A; Corradi D; Belletti S; Albarello L; Becchi G; Fadini GP; Schuetz C; Markmann J; Wasserfall C; Zon L; Zuccotti GV; Fiorina P
Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141886
[TBL] [Abstract][Full Text] [Related]
2. Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes.
Zhang X; Kang Y; Wang J; Yan J; Chen Q; Cheng H; Huang P; Gu Z
Adv Mater; 2020 Jul; 32(26):e1907692. PubMed ID: 32449212
[TBL] [Abstract][Full Text] [Related]
3. B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice.
Chen K; Xue Q; Liu F; Liu L; Yu C; Bian G; Zhang K; Fang C; Song J; Ju G; Wang J
Mol Immunol; 2019 Oct; 114():289-298. PubMed ID: 31419705
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 Stimulates the Expansion of Regulatory Hematopoietic Stem and Progenitor Cells in Type 1 Diabetes.
Ben Nasr M; D'Addio F; Malvandi AM; Faravelli S; Castillo-Leon E; Usuelli V; Rocchio F; Letizia T; El Essawy AB; Assi E; Mameli C; Giani E; Macedoni M; Maestroni A; Dassano A; Loretelli C; Paroni M; Cannalire G; Biasucci G; Sala M; Biffi A; Zuccotti GV; Fiorina P
Front Immunol; 2018; 9():1387. PubMed ID: 29971065
[TBL] [Abstract][Full Text] [Related]
5. PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.
Li R; Lee J; Kim MS; Liu V; Moulik M; Li H; Yi Q; Xie A; Chen W; Yang L; Li Y; Tsai TH; Oka K; Chan L; Yechoor V
Diabetes; 2015 Feb; 64(2):529-40. PubMed ID: 25332429
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
[TBL] [Abstract][Full Text] [Related]
7. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
[TBL] [Abstract][Full Text] [Related]
8. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
[TBL] [Abstract][Full Text] [Related]
9. Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes.
Falcone M; Fousteri G
Front Endocrinol (Lausanne); 2020; 11():569. PubMed ID: 32973682
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic
Li C; Course MM; McNeish IA; Drescher CW; Valdmanis PN; Lieber A
Cancer Res; 2020 Feb; 80(3):549-560. PubMed ID: 31727629
[TBL] [Abstract][Full Text] [Related]
11. Human stem cell derived beta-like cells engineered to present PD-L1 improve transplant survival in NOD mice carrying human HLA class I.
Santini-González J; Castro-Gutierrez R; Becker MW; Rancourt C; Russ HA; Phelps EA
Front Endocrinol (Lausanne); 2022; 13():989815. PubMed ID: 36506044
[TBL] [Abstract][Full Text] [Related]
12. PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
Pauken KE; Jenkins MK; Azuma M; Fife BT
Diabetes; 2013 Aug; 62(8):2859-69. PubMed ID: 23545706
[TBL] [Abstract][Full Text] [Related]
13. Stat5b/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes.
Ullah Khan F; Khongorzul P; Gris D; Amrani A
Int Immunopharmacol; 2024 May; 133():112166. PubMed ID: 38678673
[TBL] [Abstract][Full Text] [Related]
14. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
[TBL] [Abstract][Full Text] [Related]
15. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy.
Lin S; Huang G; Cheng L; Li Z; Xiao Y; Deng Q; Jiang Y; Li B; Lin S; Wang S; Wu Q; Yao H; Cao S; Li Y; Liu P; Wei W; Pei D; Yao Y; Wen Z; Zhang X; Wu Y; Zhang Z; Cui S; Sun X; Qian X; Li P
MAbs; 2018; 10(8):1301-1311. PubMed ID: 30204048
[TBL] [Abstract][Full Text] [Related]
16. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Cell Infiltration Into Islets Without PD-L1 Expression Is Associated With the Development of Immune Checkpoint Inhibitor-Related Type 1 Diabetes in Genetically Susceptible Patients.
Kawata S; Kozawa J; Yoneda S; Fujita Y; Kashiwagi-Takayama R; Kimura T; Hosokawa Y; Baden MY; Uno S; Uenaka R; Namai K; Koh Y; Tomimaru Y; Hirata H; Uemura M; Nojima S; Morii E; Eguchi H; Imagawa A; Shimomura I
Diabetes; 2023 Apr; 72(4):511-519. PubMed ID: 36657987
[TBL] [Abstract][Full Text] [Related]
18. Maturation of hematopoietic stem cells from prehematopoietic stem cells is accompanied by up-regulation of PD-L1.
Tober J; Maijenburg MMW; Li Y; Gao L; Hadland BK; Gao P; Minoura K; Bernstein ID; Tan K; Speck NA
J Exp Med; 2018 Feb; 215(2):645-659. PubMed ID: 29282253
[TBL] [Abstract][Full Text] [Related]
19. MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.
Zhang M; Racine JJ; Lin Q; Liu Y; Tang S; Qin Q; Qi T; Riggs AD; Zeng D
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2329-E2337. PubMed ID: 29463744
[TBL] [Abstract][Full Text] [Related]
20. Immunological applications of stem cells in type 1 diabetes.
Fiorina P; Voltarelli J; Zavazava N
Endocr Rev; 2011 Dec; 32(6):725-54. PubMed ID: 21862682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
